SCHEMBL24704281

SCHEMBL24704281

C[C@H]1[C@H]2C[C@H](c3ncn(Cc4ccc5c(c4)n(C)c(=O)n5C)c3C3CC3)C[C@@H]12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 5/20 0.35
▸ L3MBTL1 Q9Y468 2/20 0.35
▸ TSHR P16473 1/20 0.35
▸ LMNA P02545 3/20 0.35
▸ HTT P42858 3/20 0.35
▸ UBE2N P61088 2/20 0.35
▸ TRIM24 O15164 2/20 0.33
▸ POLB P06746 2/20 0.33
▸ BRD4 O60885 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ GLA P06280 1/20 0.32
▸ BRD1 O95696 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ PKM P14618 1/20 0.32
▸ ALOX12 P18054 1/20 0.32
▸ BRPF1 P55201 1/20 0.32
▸ RAD52 P43351 1/20 0.32
▸ ABCC8 Q09428 1/20 0.32
▸ KCNJ11 Q14654 1/20 0.32
▸ RXFP1 Q9HBX9 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29490310 0.87 TRIM24 (0.42) SMN1; SMN2L3MBTL1TSHRLMNAHTT
SCHEMBL22862779 0.87 TRIM24 (0.40) SMN1; SMN2L3MBTL1TSHRLMNAHTT
SCHEMBL22862638 0.87 TRIM24 (0.42) SMN1; SMN2L3MBTL1TSHRLMNAHTT
SCHEMBL29490202 0.87 TRIM24 (0.42) SMN1; SMN2L3MBTL1TSHRLMNAHTT
SCHEMBL22862953 0.87 TRIM24 (0.42) SMN1; SMN2L3MBTL1TSHRLMNAHTT
SCHEMBL22862855 0.83 SMN1; SMN2 (0.37) SMN1; SMN2L3MBTL1TSHRLMNAHTT
SCHEMBL29490249 0.83 SMN1; SMN2 (0.37) SMN1; SMN2L3MBTL1TSHRLMNAHTT
SCHEMBL22862856 0.81 SMN1; SMN2 (0.37) SMN1; SMN2L3MBTL1TSHRLMNAHTT
SCHEMBL29490177 0.81 SMN1; SMN2 (0.37) SMN1; SMN2L3MBTL1TSHRLMNAHTT
SCHEMBL22862915 0.78 SMN1; SMN2 (0.33) SMN1; SMN2L3MBTL1TSHRLMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220389028-A1 BAX INHIBITORS AND USES THEREOF CASE WESTERN RESERVE UNIVERSITY 2022-12-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220389028-A1 BAX INHIBITORS AND USES THEREOF BAX, TMBIM6, BCL2 SMN1; SMN2 2633/4885L3MBTL1 241/4885TSHR 4763/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback